Drugs / Mesenchymal Precursor Cells (MPCs)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00721045 Comparator | Aug 2008 → Jun 2011 | heart failure | Mesoblast, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mesenchymal Precursor Cells (MPCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00721045 ↗ |
| Modality | Cell therapy | “immunoselected, culture expanded, nucleated, allogeneic MPCs” NCT00721045 ↗ |
| Route | Other | “by transendocardial injection” NCT00721045 ↗ |